Caxton Associates (New York)’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-1,457
Closed -$356K – 376
2018
Q3
$356K Buy
+1,457
New +$337K 0.02% 294
2017
Q3
– Sell
-4,362
Closed -$416K – 554
2017
Q2
$416K Buy
4,362
+200
+5% +$17.1K 0.02% 396
2017
Q1
$323K Buy
+4,162
New +$288K ﹤0.01% 338

Other funds holding INGN

Caxton Associates (New York)'s INGN Position: Q4 2018 in Review

Caxton Associates (New York) sold out of Inogen (INGN) in Q4 2018, closing a stake of 1,457 shares — an estimated $356K sold.

Caxton Associates (New York) first reported a position in INGN in Q1 2017 and held it in 3 quarters. The position peaked at $416K in Q2 2017. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

  • Caxton Associates (New York) reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,457 Inogen shares in Q4 2018, an estimated $356K.
  • Caxton Associates (New York) first reported a position in Inogen in Q1 2017 and held it in 3 quarters.
  • Caxton Associates (New York)'s Inogen position peaked at $416K in Q2 2017.
  • 271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on Caxton Associates (New York)'s 13F filing for Q4 2018, filed 14 Feb 2019.